The PharmaJet Tropis Intradermal (ID) Needle-free Injection System will be used to deliver approximately 1.4 million polio vaccine doses in a Nigerian campaign. To date, supplies for more than 20 ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company who has developed and commercialized an intradermal needle-free platform to more effectively administer drugs and biologics, today announced that ...

PharmaJet ®, a company focused on improving the performance and outcomes of injectables through needle-free injection technology, announced that its partner, Brazilian Tuberculosis Research Network ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, the maker of innovative, needle-free injection technology, announced that their latest partnerships and research results will be presented at the World ...

PharmaJet® to Highlight the Benefits of Intradermal Needle-free Delivery and Expansion into the Self-Injection Pen Market at Upcoming PODD Conference PharmaJet will deliver two presentations on ...

During the week of April 6, Master Trainers conducted Tropis training in nine Local Government Regions (LGAs). Here a trainee hones her needle-free technique by administering practice injections into ...

The MarketWatch News Department was not involved in the creation of this content. -- PharmaJet's Needle-free intradermal (ID) injection device ("Tropis(R) ID") will be evaluated as delivery system for ...

PharmaJet, a global leader in needle-free injection technology, today announced that its WHO-prequalified Tropis ID Needle-free Injection System will be used to deliver approximately 1.4 million doses ...